Athanassios (ethan) Argiris MD, PhD, FACP

Dr. Athanassios (Ethan) Argiris is Professor of Medical Oncology at Thomas Jefferson University, Philadelphia, Pennsylvania, USA, and a consultant medical oncologist at Hygeia Hospital in Athens, Greece. He received his medical degree from the University of Athens Medical School. From 1994-2013, he held positions at several prestigious academic institutions in the United States. He trained in internal medicine at Mount Sinai Beth Israel and in medical oncology at Yale University. After serving on the faculty of Northwestern University as an Assistant Professor from 2000-2005, he joined the faculty at the University of Pittsburgh where he was promoted to Professor of Medicine in 2009. From 2011-2013 he was Professor and Chief of Hematology/Oncology at the University of Texas Health Science Center at San Antonio and the holder of the A.B. Alexander Distinguished Chair in Oncology.

He is currently an Adjunct Professor at University of Texas and was elected Visiting Professor at the University of Crete in 2011. Dr. Argiris is the founding president of the Hellenic Society of Head and Neck Oncology (HeSHNO). He is also a member of several international oncology organizations, including the Eastern Cooperative Oncology Group (ECOG), SWOG, European Organization for Research and Treatment of Cancer, American Society of Clinical Oncology (ASCO), and ESMO.

Professor Argiris’ research has been internationally recognized and focuses on the development of targeted and personalized therapies for head and neck cancers, as well as lung cancers. He has served as a principal investigator for more than 50 clinical trials and has published more than 250 articles and abstracts. His studies relating to head and neck cancers have included targeted therapies, immunotherapy, and combination chemoradiotherapy. He is also an Associate Editor for the journal Head and Neck and has served on the editorial boards of several journals, including the Journal of Clinical Oncology.